4001 radiopharmaceuticals

Ended Awarded Last action

Contract number
N6264522F0002
Awardee
Awarding agency
Obligated
$549,911

Award facts

Opportunity
  • N6264521R0053 Solicitation number
Contract value 98% obligated
$561,589.91 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Jacksonville, FL 32214, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00013 -$2,200
Funding Only Action P00012 $117,843
Other Administrative Action P00011 $0
Exercise an Option P00010 $0
Funding Only Action P00009 · Radiopharmaceuticals $115,173
Exercise an Option P00008 $0
Other Administrative Action P00007 · Radiopharmacutical supplies $112,569
Exercise an Option P00006 $0
Other Administrative Action P00005 · Radiopharmaceuticals jacksonville FL $109,965
Exercise an Option P00004 · Radiopharmaceuticals $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $96,561
Other Administrative Action P00001 $0
Original award $0
Show all 14

About this award

The Defense Health Agency issued a $561,589.91 delivery order to Cardinal Health 414, LLC on October 7, 2021, for radiopharmaceuticals with an ultimate completion date of September 30, 2026.

Place of performance is Jacksonville, FL 32214. Cardinal Health 414, a subsidiary of Cardinal Health, Inc., manufactures and distributes radiopharmaceuticals and medical isotopes including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 fluorodeoxyglucose, and gallium-67, as well as exclusive-rights therapeutics including Xofigo for prostate cancer treatment and Lymphoseek for lymph node imaging. The company holds Nuclear Regulatory Commission licensing and FDA approvals for radiopharmaceutical manufacturing and maintains Department of Transportation compliance for radioactive materials transport. Delivery orders typically carry expedited delivery requirements—daily morning deliveries by 7:00 AM at no additional charge, with emergency response within one to two hours—to accommodate short radioactive half-lives. The order is priced on a firm fixed-price basis with no set-aside designation. Cardinal Health 414 operates exclusively through indefinite-delivery contracts and blanket purchase agreements, with no subcontractor teaming in its federal radiopharmaceutical footprint.

Quick answers

Who was awarded contract N6264522F0002?

N6264522F0002 was awarded to Cardinal Health 414, LLC by Defense Health Agency (Department of Defense) on October 7, 2021.

How much is contract N6264522F0002 worth?

The government has obligated $549,911 on N6264522F0002. Its current value, with exercised options, is $561,590.

Is contract N6264522F0002 an order under another contract?

Yes. N6264522F0002 is a delivery order under N6264521D5018, an indefinite delivery contract.

Was contract N6264522F0002 competed?

The extent of competition for N6264522F0002 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award